No. of items: 266
Sorting after results
02/12/2020
German contract research specialist key to making COVID vaccine
Rentschler Biopharma, a leading German contract development and manufacturing organization (CDMO), is playing a vital role in making the BioNTech and Pfizer's vaccine for COVID-19, BNT162b2. The Laupheim-based company has been responsible for essential purification of the products of mRNA synthesis.
24/11/2020
Germany holds innovation hackathon to help conquer COVID
Germany's Federal Ministry of Education and Research (BMBF) has announced the results of its #WirVsVirus (#WeVsVirus) contest. With more than 28 thousand taking part and 1,500 projects submitted, the hackathon, says the BMBF, was one of the largest in the world.
17/11/2020
German-US cooperation yields effective vaccine for COVID-19
The German life-sciences company BioNTech and US pharmaceuticals giant Pfizer have announced their vaccine against SARS-CoV-2 prevents COVID-19 in most cases. They report that the interim analysis of the Phase 3 clinical trial found the mRNA-based candidate BNT162b2 to be more than 90% effective in …
10/11/2020
US companies say Germany is a top business location
American companies continue to rate Germany as one of the best places in the world to do business. The American Chamber of Commerce in Germany, AmCham, reports that US business active in Germany have given the country even higher marks than in the past for its performance in 2019.
27/10/2020
Germany sets up cancer research center at four more sites
Germany's National Center for Tumor Diseases (Nationales Zentrum für Tumorerkrankung, NCT) is opening new facilities in Berlin, Cologne/Essen, Tübingen/Stuttgart-Ulm, and Würzburg. The NCT is a key component of cancer research in Germany.
13/10/2020
Competition to spur on innovation
Germany's Federal Ministry of Education and Research (BMBF) has announced the winners of a competition aimed ultimately at helping patients who are waiting for donated organs. The top prizes in the Organersatz aus dem Labor (Laboratory-Grown Replacement Organs) contest were taken by projects …
15/09/2020
Study shows medical biotechnology flourishing in Germany
A Boston Consulting Group (BCG) report indicates that Germany's medical biotechnology industry continues to grow and increase its market share. The survey found that biopharmaceuticals earned EUR 12.7 billion in revenue 2019, or 13 percent more than in the previous year, while the entire …
25/08/2020
Two German cities among global leaders in cancer research
World Health Organization (WHO) statistics show that cancer is the world's second leading cause of death. The WHO estimates the total economic cost of cancer is greater than USD 1.16 trillion worldwide.
18/08/2020
University hospitals play key role in fight against coronavirus in Germany
Germany's teaching hospitals are working together with industry and basic research to devise novel ways to combat and treat COVID-19. The German Federal Ministry of Education and Research (BMBF) is supporting these efforts with millions of euros in funding.
11/08/2020
German medical biotechnology broadens international cooperation
The German life sciences company CureVac has signed a strategic collaboration agreement with GlaxoSmithKline (GSK). The accord provides for research, development, manufacture, and commercialization of as many as five messenger RNA (mRNA)-based vaccines and monoclonal antibodies (mAbs) that target …
- Recommend this page:
- Print view